KR860004634A - 데오필린-함유 서방성 제제의 제조방법 - Google Patents

데오필린-함유 서방성 제제의 제조방법

Info

Publication number
KR860004634A
KR860004634A KR1019850009678A KR850009678A KR860004634A KR 860004634 A KR860004634 A KR 860004634A KR 1019850009678 A KR1019850009678 A KR 1019850009678A KR 850009678 A KR850009678 A KR 850009678A KR 860004634 A KR860004634 A KR 860004634A
Authority
KR
South Korea
Prior art keywords
preparing
sustained release
release formulation
formulation containing
containing theophylline
Prior art date
Application number
KR1019850009678A
Other languages
English (en)
Other versions
KR920006910B1 (ko
Inventor
베네딕트 제랄트
스타이니잔스 폴커
Original Assignee
비크 굴덴 롬베르그 케미쉐 파브리크 지엠비에이치
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비크 굴덴 롬베르그 케미쉐 파브리크 지엠비에이치 filed Critical 비크 굴덴 롬베르그 케미쉐 파브리크 지엠비에이치
Publication of KR860004634A publication Critical patent/KR860004634A/ko
Application granted granted Critical
Publication of KR920006910B1 publication Critical patent/KR920006910B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1019850009678A 1984-12-21 1985-12-21 데오필린-함유 서방성 제제의 제조방법 KR920006910B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH6111/84-6 1984-12-21
CH268385 1985-06-24
CH2683/85-5 1985-06-24

Publications (2)

Publication Number Publication Date
KR860004634A true KR860004634A (ko) 1986-07-11
KR920006910B1 KR920006910B1 (ko) 1992-08-22

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850009678A KR920006910B1 (ko) 1984-12-21 1985-12-21 데오필린-함유 서방성 제제의 제조방법

Country Status (20)

Country Link
US (1) US4803080A (ko)
EP (1) EP0185331B1 (ko)
KR (1) KR920006910B1 (ko)
CN (1) CN1008060B (ko)
AU (1) AU581274B2 (ko)
BG (1) BG60833B2 (ko)
CA (1) CA1261268A (ko)
CS (1) CS396391A3 (ko)
DE (1) DE3572924D1 (ko)
DK (1) DK164843C (ko)
ES (1) ES8704079A1 (ko)
FI (1) FI84782C (ko)
GR (1) GR853051B (ko)
HU (1) HU193359B (ko)
IE (1) IE58246B1 (ko)
IL (1) IL77322A (ko)
NO (1) NO171827C (ko)
NZ (1) NZ214534A (ko)
PT (1) PT81714B (ko)
SK (1) SK278868B6 (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
KR20070095456A (ko) * 2005-01-27 2007-09-28 알렘빅 리미티드 레베티라세탐의 서방형 제제
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
CA2841748C (en) 2011-07-15 2021-06-15 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
CN108295058A (zh) 2012-11-13 2018-07-20 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
US20150359771A1 (en) 2013-01-15 2015-12-17 Nusirt Sciences, Inc. Treating pulmonary conditions
EP2968333B1 (en) 2013-03-15 2022-01-12 NuSirt Sciences, Inc. Leucine and nicotinic acid for the reduction of lipid levels
KR20160119863A (ko) 2014-02-27 2016-10-14 뉴서트 사이언시스, 인크. 간 지방증의 감소 또는 예방을 위한 조성물 및 방법
EP3284795B1 (en) * 2015-04-16 2023-08-02 The School Corporation Kansai University Use of a purine base-containing polymer as an anti-ice nucleation activator
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (en) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1091289B (de) * 1956-01-25 1960-10-20 Hans Lowey Verfahren zur Herstellung einer oral anzuwendenden Arzneiform mit verlaengerter Wirkungsdauer
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
ATE34300T1 (de) * 1981-07-15 1988-06-15 Key Pharma Theophyllin mit verlaengerter abgabe.
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DE3572924D1 (en) 1989-10-19
NO171827C (no) 1993-05-12
CN85109688A (zh) 1986-06-10
PT81714A (de) 1986-01-01
IL77322A (en) 1990-07-12
NO171827B (no) 1993-02-01
ES550291A0 (es) 1987-04-01
CN1008060B (zh) 1990-05-23
DK164843B (da) 1992-08-31
EP0185331B1 (de) 1989-09-13
EP0185331A1 (de) 1986-06-25
AU581274B2 (en) 1989-02-16
BG60833B2 (bg) 1996-04-30
AU5161885A (en) 1986-07-17
HUT40334A (en) 1986-12-28
KR920006910B1 (ko) 1992-08-22
FI84782B (fi) 1991-10-15
NZ214534A (en) 1988-08-30
FI84782C (fi) 1992-01-27
PT81714B (pt) 1988-04-21
NO855215L (no) 1986-06-23
IE58246B1 (en) 1993-08-11
CS396391A3 (en) 1992-06-17
SK278868B6 (sk) 1998-04-08
DK600485D0 (da) 1985-12-20
IE853107L (en) 1986-06-21
CA1261268A (en) 1989-09-26
DK164843C (da) 1993-01-11
ES8704079A1 (es) 1987-04-01
FI854973A0 (fi) 1985-12-16
US4803080A (en) 1989-02-07
GR853051B (ko) 1986-02-03
DK600485A (da) 1986-06-22
FI854973A (fi) 1986-06-22
HU193359B (en) 1987-09-28

Similar Documents

Publication Publication Date Title
NO170516C (no) Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat
KR860004634A (ko) 데오필린-함유 서방성 제제의 제조방법
ES540441A0 (es) Procedimiento de preparar derivados de acidos naftiridin- quinolin- y benzoxazin-carboxilicos
ES542051A0 (es) Un procedimiento para preparar derivados de benzoilurea
ES540443A0 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES523199A0 (es) "un metodo para preparar derivados de acidos vinil-carboxilicos"
EG17979A (en) Method for preparing injectable sustained release formulation from somatotropine
ES551064A0 (es) Un metodo para preparar derivados de cefem
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
KR860004922A (ko) N-포르밀-α-아스파르틸페닐알라닌의 제조방법
KR860005834A (ko) N-보호된-α-L-아스파르틸-L-페닐알라닌 메틸 에스테르의 제조방법
ES552911A0 (es) Un procedimiento para preparar derivados de 3-carbonil-1-aminoalquil-1h-indol
ES550466A0 (es) Un metodo para preparar derivados de 9-bencilpurina
FI93172C (fi) Menetelmä hajunpoistoaineen valmistamiseksi
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
FI885045A0 (fi) Menetelmä polynukleotidien valmistamiseksi
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
EP0189878A3 (en) Process for preparing optically active glycerol derivates
KR870004928A (ko) m-히드록시벤질알코올의 제조방법
ZA859645B (en) Theophylline sustained release formulation
KR860004877A (ko) 카보스티릴 화합물의 제조방법
DK214385D0 (da) Fremgangsmaade til fremstilling af en valse
IT8422800A1 (it) Procedimento per preparare arilalchilchetoni

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990729

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee